Projects per year
Personal profile
Education
- 2014-2020 Ph.D., The Ph.D. Program for Translational Medicine, Taipei Medical University
- 2000-2007 M.D., School of Medicine, College of Medicine, Taipei Medical University
Experience
- 2024.08- Associate Professor, Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University
- Attending Physician, Taipei Medical University Hospital
- 2021.01- Director, Division of Radiation Oncology, Taipei Medical University Hospital
- 2020.11-2024.07 Assistant Professor, Department of Radiology, School of Medicine, College of Medicine, Taipei Medical University
- 2019.08-2020.12 Acting Director, Division of Radiation Oncology, Taipei Medical University Hospital
- 2014.04-2015.06 Adjunct Attending Physician, Taipei Medical University Hospital
- 2013.04-2014.09 Adjunct Attending Physician, Landseed International Hospital
- 2012.11-2015.06 Attending Physician, Taipei Municipal Wanfang Hospital
Fingerprint
Dive into the research topics where Hsin-Lun Lee is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
探索奈米劑型球薑酮在頭頸癌質子放射治療中的增敏效益：機制解析、製劑開發與臨床轉譯洞察(2/3)
Lee, H.-L. (PI)
8/1/26 → 7/31/27
Project: A - Government Institution › b - National Science and Technology Council
-
應用深度學習與放射組學技術，精確預測立體定向放射外科手術後的局部腦部復發
Lee, H.-L. (PI)
1/1/26 → 12/31/26
Project: B - Project of TMU › i - Other (Funded by TMU)
-
Exploring the Radiotherapeutic Potentiation of Nanoformulated Zerumbone in Proton Therapy for Head and Neck Cancer: Mechanistic Insights, Formulation Development, and Translational Perspectives
Lee, H.-L. (PI)
8/1/25 → 7/31/26
Project: A - Government Institution › b - National Science and Technology Council
-
應用深度學習與放射組學技術，精確預測立體定向放射外科手術後的局部腦部復發
Lee, H.-L. (PI)
1/1/25 → 12/31/25
Project: B - Project of TMU › i - Other (Funded by TMU)
-
The Development of Combined Hyperthermia and Proton Therapy to Overcome the Metabolic Compensation in Radioresistant Head and Neck Squamous Cell Carcinoma
Lee, H.-L. (PI)
8/1/23 → 7/31/24
Project: A - Government Institution › b - National Science and Technology Council
-
A heavy-chain antibody-drug conjugate targeting glycosylated CEACAM6 inhibits brain metastatic tumor growth
Tsai, Y. T., Yen, M. H., Hu, P. J., Lee, C. C., Liu, C. Y., Cheng, T. M., Shen, H. T., Benjamin Zhang, B. X., Lee, H. L., Chuang, K. H., Yap, C. V., Wang, W. C. & Wu, M. H., Jun 28 2026, In: Cancer Letters. 648, 218463.Research output: Contribution to journal › Article › peer-review
-
Critical radiosensitizing parameters of dual-modality gold nanodandelion against cancer radioresistance in MV X-ray and proton therapies
Chuang, Y. C., Chiou, J. F., Wu, P. H., Shen, Y. A., Chang, W. M., Hsia, Y., Kuo, C. C., Wang, W. J., Lo, L. W. & Lee, H. L., Jun 2026, In: Materials Today Advances. 30, 100757.Research output: Contribution to journal › Article › peer-review
Open Access -
Multicenter validation and randomized crossover reader evaluation of deep learning-assisted tri-sequence three-dimensional MRI segmentation for hypopharyngeal tumor
Hsu, C., Ku, H. L., Lin, S. M., Lee, H. L., Lee, I. H., Chen, K. Y., Chen, Y. L., Liu, K. L., Chen, P. T., Chen, R. Y., Tsai, H. H., Yang, T. L., Lai, S. F., Chiou, J. F., Kuo, S. H., Wang, C. W. & Wang, W., Aug 2026, In: Radiotherapy and Oncology. 221, 111606.Research output: Contribution to journal › Article › peer-review
-
Targeting glutamine metabolism combined with a nanoradioenhancer in radioresistant hepatocellular carcinoma
Kuo, C. C., Chuang, Y. C., Wu, P. H., Chang, W. M., Lo, L. W., Chen, H. Y., Lee, K. H., Lee, H. L., Chiou, J. F. & Shen, Y. A., 2026, (Accepted/In press) In: Nanoscale.Research output: Contribution to journal › Article › peer-review
-
ACSL6 modulates docosahexaenoic acid-induced cytotoxicity to potentiate chemotherapy response in colorectal and breast cancer
Chen, I. S., Hsieh, C. C., Li, C. C., Wei, Y. L., Cheng, C. C., Feng, S. W., Lee, H. L., Chiang, N. J., Shen, C. H. & Hsu, H. P., Dec 2025, In: Oncogenesis. 14, 1, 45.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Citation (Scopus)
Datasets
-
Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, I.-C. (Contributor), Lai, G.-M. (Contributor), Chow, J.-M. (Contributor), Lee, H.-L. (Contributor), Yeh, C.-F. (Creator), Li, C.-H. (Contributor), Yan, J.-L. (Contributor), Chuang, S.-E. (Contributor), Whang-Peng, J. (Creator), Bai, K.-J. (Contributor) & Yao, C.-J. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717.v1
Dataset
-
Loco-regional deep hyperthermia combined with intravesical Mitomycin instillation reduces the recurrence of non-muscle invasive papillary bladder cancer
Wen, Y.-C. (Creator), Lee, L.-M. (Creator), Lin, Y.-W. (Creator), Syu, S.-H. (Creator), Lin, K.-H. (Creator), Fan, Y.-C. (Creator), Lee, H.-L. (Creator), Lai, B. C. H. (Creator) & Shih, H.-J. (Creator), Taylor & Francis, 2021
DOI: 10.6084/m9.figshare.17009635.v1, https://tandf.figshare.com/articles/journal_contribution/Loco-regional_deep_hyperthermia_combined_with_intravesical_Mitomycin_instillation_reduces_the_recurrence_of_non-muscle_invasive_papillary_bladder_cancer/17009635/1
Dataset
-
MOESM1 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Lai, G.-M. (Contributor), Li, C.-H. (Contributor), Yeh, C.-F. (Creator), Whang-Peng, J. (Creator), Lee, H.-L. (Contributor), Yao, C.-J. (Contributor), Lai, I.-C. (Contributor), Chuang, S.-E. (Contributor), Chow, J.-M. (Contributor), Bai, K.-J. (Contributor) & Yan, J.-L. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717_d1.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717_d1.v1
Dataset
-
MOESM2 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Chuang, S.-E. (Contributor), Lai, I.-C. (Contributor), Yeh, C.-F. (Creator), Yan, J.-L. (Contributor), Yao, C.-J. (Contributor), Whang-Peng, J. (Creator), Li, C.-H. (Contributor), Chow, J.-M. (Contributor), Bai, K.-J. (Contributor), Lee, H.-L. (Contributor) & Lai, G.-M. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717_d2.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717_d2.v1
Dataset
-
MOESM3 of Active fraction (HS7) from Taiwanofungus camphoratus inhibits AKT-mTOR, ERK and STAT3 pathways and induces CDK inhibitors in CL1-0 human lung cancer cells
Whang-Peng, J. (Creator), Chow, J.-M. (Contributor), Yan, J.-L. (Contributor), Lee, H.-L. (Contributor), Yeh, C.-F. (Creator), Lai, I.-C. (Contributor), Yao, C.-J. (Contributor), Lai, G.-M. (Contributor), Bai, K.-J. (Contributor), Chuang, S.-E. (Contributor) & Li, C.-H. (Contributor), Figshare, 2017
DOI: 10.6084/m9.figshare.c.3931717_d3.v1, https://doi.org/10.6084%2Fm9.figshare.c.3931717_d3.v1
Dataset